Ocugen (OCGN) announced positive preliminary efficacy and safety data from the Phase 1 dose-escalation portion of the Phase 1/2 OCU410 ArMaDa ...

Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...

And in Stargardt disease, when patients develop lesions that affect the macular, they inevitably lose vision over time, and eventually lose many letters. A significant vision loss, defined by the ...

Dosed first patient in Phase 2/3 DRAGON II trial of Tinlarebant for the treatment of Stargardt disease (STGD1)Pivotal global Phase 3 PHOENIX ...

The lesions show up on imaging like a map ... Knowing about the threat of age-related macular degeneration can keep you seeing clearly far into the future. Syed Jamal teachers college-level chemistry, ...

AMN is characterized by dark reddish macular lesions and retinal ischemia, with bilateral ocular changes noted in most patients. Retinal perfusion deficits and inner retinal changes were identified, ...

A study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or "wet" AMD) fail to have vision ...

The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions.2 Impairment of the retinal deep capillary plexus also occurs and suggests ischemia ...